2024-520291-10-01招募中4 期
Prospective Randomised Nordic Frostbite Treatment Study comparing tPA and iloprost therapy
HUS-Yhtymae5 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年1月30日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 100
- 试验地点
- 5
- 主要终点
- level of distal extremity / digital amputation
研究概览
简要总结
To randomize into 2 groups all severe cases of frostbite to be treated with iloprost or tPA as non-inferiority trial. Prospective data will be collected and clinical outcome recorded. The aim is to accrue at least 50 patients and review rates and levels of distal extremity amputations as well as long-term functional outcome. Furthermore various haematological variables will be recorded prior to and after treatment.
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 否
入选标准
- •Severe distal extremity frostbite
排除标准
- •Contraindications to either tPA or iloprost therapy, less than 18 years age, non-severe frostbite
结局指标
主要结局
level of distal extremity / digital amputation
level of distal extremity / digital amputation
次要结局
未报告次要终点
研究者
Andrew Lindford
Scientific
HUS-Yhtymae
研究点 (5)
Loading locations...
相似试验
尚未招募
3 期
Efficacy and Safety of Cryotherapy Followed by Tirbanibulin Ointment for Actinic Keratosis on the Scalp and ForeheadNCT07273656University Hospital, Lille59
招募中
4 期
Frozen Shoulder Treatment with IA Corticosteroid Injection and Suprascapular Nerve Block2024-513057-78-00UZ Brussel156
招募中
3 期
Prevention of thrombotic events in the context of long distance flights2024-515630-33-00Klinikum der Universitaet Muenchen AöR27,698
招募中
1 期
A Phase IB Study to determine efficacy and safety of Durvalumab and/or novel anti-cancer agents, with or without chemotherapy, in patients with previously untreated NSCLC2024-511956-42-00AstraZeneca AB44
已完成
不适用
Comparison of Bier Block and Lidocaine-Propofol Mixture for Prevention of Propofol Injection PainNCT07285980Asma Ladib180